Publications

5538 Results

The influence of beam energy on the outcome of postoperative radiotherapy in head and neck cancer patients: secondary analysis of RTOG 85-03

Authors
A Aref;BA Berkey;JG Schwade;J Ensley;DE Schuller;RE Haselow;TJ Ervin;GE Laramore
Journal / Conference
Int J Radiat Oncol Biol Phys 47(2):389-394
Year
2000
Research Committee(s)
Head and Neck
Study Number(s)
SWOG-8590 (INT-0034)

Tumor suppressor gene aberrations in acute myelogenous leukemia

Authors
DL Stirewalt;JP Radich
Journal / Conference
Hematology 5:15-25
Year
2000
Research Committee(s)
Leukemia

Improved five years survival with chemo-radiotherapy (CT-RT) vs radiotherapy (RT) in patients (PTS) with advanced nasopharyngeal cancer (NPC). Intergroup (0099) (SWOG 8892, RTOG 8817, ECOG 2388) phase III study: progress report.

Authors
M Al-Sarraf;M LeBlanc;PGS Giri;K Fu;J Cooper;T Vuong;A Forastiere;G Adams;W Sakr;D Schuller;J Ensley
Journal / Conference
Annals of Oncology 11(Suppl.4):90(#403)
Year
2000
Research Committee(s)
Head and Neck
Study Number(s)
SWOG-8892 (INT-0099) (EST-2388) (RTOG-8817)

Phase III trials in patients with advanced stage non-small cell lung cancer: the experience in North America from 1973-1994.

Authors
OS Breathnach;B Freidlin;B Conlay;MR Green;DJ Johnson;DR Gandara;M O'Connell;R Simon;BE Johnson
Journal / Conference
Lung Cancer 29(Suppl.2):20(#62)
Year
2000
Research Committee(s)
Lung

Comparison of quality of life (QLI) outcomes for two chemotherapy regimens in non-small cell lung cancer (NSCLC).

Authors
CM Moinpour;B Lyons;LC Lovato;PK Grevstad;K Kelly;J Crowley;D Gandara
Journal / Conference
Lung Cancer 29(Suppl.2):34(#109)
Year
2000
Research Committee(s)
Lung

Response to chemotherapy as a predictor of survival in advanced non-small cell lung cancer (NSCLC): review of the Southwest Oncology Group (SWOG) database.

Authors
W Akerley;J Crowley;D Giroux;D Gandara
Journal / Conference
Lung Cancer 29(Suppl.2):33(#106)
Year
2000
Research Committee(s)
Lung

Pathologic stage IIIb non-small cell lung cancer (NSCLC): prolonged survival with consolidation docetaxel following concurrent chemoradiotherapy (SWOG 9504).

Authors
DR Gandara;LC Lovato;KS Albain;B Leigh;PN Lara;JJ Crowley;RB Livingston
Journal / Conference
Lung Cancer 29(Suppl.2):92(#302)
Year
2000
Research Committee(s)
Lung
Study Number(s)
SWOG-9504

An economic analysis alongside a prospective randomized multicenter clinical trial of cisplatin/vinorelbine vs. carboplatin/paclitaxel for advanced non small cell lung cancer.

Authors
SD Ramsey;CM Moinpour;LC Lovato;PK Grevstad;C Presant;DR Gandara;K Kelly
Journal / Conference
Lung Cancer 29(Suppl.2):4(#5)
Year
2000
Research Committee(s)
Lung
Study Number(s)
SWOG-9509

A phase II study of cisplatin, etoposide, and paclitaxel (PET) with G-CSF in untreated patients with extensive small cell lung cancer: a Southwest Oncology Group trial.

Authors
K Kelly;PA Bunn;L Lovato;J Crowley;RB Livingston;DR Gandara
Journal / Conference
Lung Cancer 29(Suppl.2):8(#20)
Year
2000
Research Committee(s)
Lung
Study Number(s)
S9705

Letter to the editor: Observational studies and randomzied trials

Authors
PY Liu;G Anderson;JJ Crowley
Journal / Conference
New England Journal of Medicine 343(16):1195
Year
2000